Partner Dan Shores will present on "Navigating a New Era in Therapeutics with mRNA and LNP Technologies" at The mRNA Conference 2024 taking place October 7-8, 2024, in Boston, Massachusetts. Dan's session will be held on Monday, October 7.
During his session, Dan will highlight the patent landscape for mRNA and lipid nanoparticle technologies; discuss patent trends and protections for mRNA and lipid nanoparticle innovations; and review the strategic frameworks to navigate complex IP and litigation issues.
At The mRNA Conference 2024, global pharmaceutical and biotech companies will meet with world-leading industry experts in Boston, Massachusetts, to explore the latest innovations in mRNA-based therapeutics and vaccines for infectious diseases, oncology, personalized treatments, and beyond. The event will showcase invaluable insights into differentiated drug platforms through RNA modification and delivery systems, next-generation mRNA therapeutics, formulations, clinical development, and supply chain and logistics.
To learn more about the event, and to register, please visit the event website.
